Neoplasm Metastasis: all 3,564 studies
Page 2 of 36. Open to participants first (875), then studies with results posted, then the rest; newest registration first within each.
- Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver CancerNot yet recruitingNCT07537946Phase 3
- Evaluating Interventional Radiology for Cancer Pain ManagementNot yet recruitingNCT07529314Not applicable
- Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic CancerNot yet recruitingNCT07528430
- A First-in-Human Study of ZE94-0605 in Patients With Advanced Solid TumorsRecruitingNCT07524140Phase 1
- Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid TumorsRecruitingNCT07523529Phase 1/2
- Diagnostic Performance of 18F-FDG PET/CT in Detecting Distant Metastases in Breast CancerNot yet recruitingNCT07523516
- Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Treatment: an Observational StudyRecruitingNCT07522762
- Exercise Training in Women With Metastatic Breast CancerNot yet recruitingNCT07521826Not applicable
- Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)Not yet recruitingNCT07521670Phase 2
- Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or NeuroblastomaNot yet recruitingNCT07518654Phase 1
- JS212 Plus JS111 in EGFR-Mutant Advanced NSCLC: A Phase II StudyRecruitingNCT07518160Phase 2
- Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/RectumNot yet recruitingNCT07511023Phase 2
- Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBCRecruitingNCT07510802Phase 1/2
- FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal CancerNot yet recruitingNCT07509398Phase 2/3
- Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The PeritoneumRecruitingNCT07509008Phase 1/2
- To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.RecruitingNCT07493421Not applicable
- Benefits of Early Collaboration Between Oncologists and Palliative Care Physicians in Cases of Unplanned Hospitalization for Patients With Metastatic CancerNot yet recruitingNCT07490106Not applicable
- Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)RecruitingNCT07486089Phase 1/2
- Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/ResistanceRecruitingNCT07483983Phase 2
- Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal AdenocarcinomaRecruitingNCT07480928Phase 1/2
- Tumor Margin Skin Tattooing Before Neo-adjuvant Chemotherapy in Patients With Breast CancerRecruitingNCT07478900Not applicable
- A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With OsteosarcomaRecruitingNCT07477457Phase 2
- Biopsy-Resection Agreement of Peritoneal Histopathological Growth Patterns in Colorectal Peritoneal Metastases: A Prospective Observational Pilot StudyRecruitingNCT07474025
- Evaluation of Endobronchial Ultrasound Needle Cleaning Techniques and Their Impact on Specimen ContaminationNot yet recruitingNCT07461662Not applicable
- Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic MalignanciesRecruitingNCT07459309Not applicable
- A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) MutationRecruitingNCT07458347Phase 1
- Study of ABO2102 in KRAS-Mutated Solid TumorsRecruitingNCT07455617Phase 1
- Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain MetastasesNot yet recruitingNCT07454668Phase 1
- Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous AdenocarcinomaNot yet recruitingNCT07454031Phase 1
- A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)RecruitingNCT07450859Phase 2
- EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and MetastasesNot yet recruitingNCT07448376
- FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal CancerNot yet recruitingNCT07446465Phase 4
- Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic HypertrophyRecruitingNCT07445412
- Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)RecruitingNCT07432295Phase 2
- Immunotherapy Master Trial for Advanced CancersRecruitingNCT07431073Phase 2
- PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate CancerRecruitingNCT07426094Phase 2/3
- A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal CancerRecruitingNCT07424664Phase 2
- A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard TherapyNot yet recruitingNCT07423117Phase 1
- Window of Opportunity in Preserving Laryngeal Function TrialRecruitingNCT07423078Phase 2
- Motor Eloquent Navigated Transcranial Magnetic Stimulation for Radiosurgery PlanningRecruitingNCT07415668Not applicable
- Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their CaregiversRecruitingNCT07415564Not applicable
- EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid TumorsRecruitingNCT07410676Phase 1/2
- Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsRecruitingNCT07410494Phase 1/2
- Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.RecruitingNCT07407465Phase 2
- Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver MetastasesNot yet recruitingNCT07406126
- Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal CancerNot yet recruitingNCT07405736Phase 2
- Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT StudyRecruitingNCT07405086Phase 4
- 5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory TumorsRecruitingNCT07404332Phase 1
- AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid TumorsRecruitingNCT07403721Phase 1
- Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study.RecruitingNCT07400809
- A Study of SH009 Injection in Patients With Advanced Solid Tumors.RecruitingNCT07390838Phase 1
- TheraSphere Japan Pre-Market StudyRecruitingNCT07377487Not applicable
- Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast CancerNot yet recruitingNCT07374796
- Validation of a Prognostic Method for Assessing the Risk of Distant Metastasis in Early-stage Breast CancerEnrolling by invitationNCT07372261
- Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the LiverRecruitingNCT07364474Not applicable
- A Phase II Study of Utidelone With Toripalimab in Advanced Cervical CancerNot yet recruitingNCT07363330Phase 2
- Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell CancerNot yet recruitingNCT07361133Phase 2
- Predicting Severe Cardiac Arrhythmias in the Perioperative Period Using AI-ECGNot yet recruitingNCT07348991
- ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.Not yet recruitingNCT07348107Phase 1
- Real-world Trial of Individualized Precision OncologyNot yet recruitingNCT07346209Phase 2
- Parental Support Intervention in an Advanced Oncological ContextRecruitingNCT07341815Not applicable
- SL-28 for Advanced Solid TumoursRecruitingNCT07341737Phase 1/2
- Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.Not yet recruitingNCT07340619Phase 2
- Intratumoral N17350 in Advanced Solid TumorsRecruitingNCT07339176Phase 1/2
- CR-001 in Adult Participants With Locally Advanced or Metastatic Solid TumorsRecruitingNCT07335497Phase 1/2
- Injection of IP-001 Into Thermally Ablated Hepatic Tumors in Patients With Colorectal Liver MetastasesNot yet recruitingNCT07321847Phase 2/3
- Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose (RADIANT)RecruitingNCT07312292Phase 2
- Golidocitinib for Refractory Immune-related Hematologic Toxicities of Advanced Lung CancerNot yet recruitingNCT07303881Phase 2
- Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional OncologyRecruitingNCT07303725
- A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1RecruitingNCT07292168Phase 1/2
- High Dose Radiotherapy for Palliation (Hi-D)Not yet recruitingNCT07291895Not applicable
- Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PETNot yet recruitingNCT07285993Phase 2
- First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid TumorsRecruitingNCT07284186Phase 1
- Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue SarcomaRecruitingNCT07283731Phase 2
- Heated Versus Aerosol-based Laparoscopic Chemotherapy for Cancer That Has Spread to the Peritoneum (Abdominal Lining)RecruitingNCT07282834Phase 2
- Phase III Study to Evaluate the Safety, Efficacy, and Impact on Quality of Life of Capivasertib Alongside Standard-of-care Endocrine Treatment in Patients With HR+/HER2- Advanced Breast Cancer and Progression on Prior Endocrine-based TreatmentRecruitingNCT07281833Phase 3
- A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsRecruitingNCT07277413Phase 1
- STM-06: POLARIS-POlymetastic Lesion Ablative Radiotherapy With Immunotherapy StudyRecruitingNCT07269080Phase 1
- EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) TumorsRecruitingNCT07262619Phase 1/2
- Immune Cell Therapy for Advanced Solid TumorsNot yet recruitingNCT07260058Phase 1/2
- Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate CancersRecruitingNCT07252726Phase 4
- Study of ACC-1898 in Adult Participants With Advanced Solid TumorsNot yet recruitingNCT07252661Phase 1
- A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid TumorsRecruitingNCT07229313Phase 1
- Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell CancerRecruitingNCT07227415Phase 1/2
- Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal CancerRecruitingNCT07222800Phase 3
- Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerRecruitingNCT07222566Phase 3
- Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] MelanomaRecruitingNCT07221734Phase 3
- A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary TractRecruitingNCT07218380Phase 3
- A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor TherapiesRecruitingNCT07213830Phase 1/2
- A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid TumoursRecruitingNCT07213817Phase 1/2
- A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian CancerRecruitingNCT07213804Phase 3
- A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast CancerRecruitingNCT07205822Phase 3
- Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell HomeostasisRecruitingNCT07203391Phase 1
- Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic CancerRecruitingNCT07197671Phase 1
- Electronic Patient Reporting of Symptoms and Unmet Needs to Connect Patients With Advanced Cancer to Palliative Care ServicesRecruitingNCT07195513Not applicable
- BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)RecruitingNCT07193511Phase 1/2
- Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast CancerRecruitingNCT07193394Phase 2
- Plant-Based Nutrition for Breast or Endometrial CancerNot yet recruitingNCT07189702Not applicable
- TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic AdenocarcinomaRecruitingNCT07189195Phase 1
- Circulating Tumor DNA Response In Urothelial CancerRecruitingNCT07183319Phase 2